{"product_id":"apgroup-bcg-matrix","title":"Amorepacific Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBCG Matrix Snapshot: Amorepacific Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003ePreview of Amorepacific's Boston Consulting Group (BCG) Matrix indicates flagship skincare and cosmetics mostly sit between Stars and Cash Cows-driven by strong domestic share amid intensifying global competition. Certain premium niche labels appear as Question Marks with growth potential, while underperforming SKUs risk becoming Dogs. Purchase the full BCG Matrix for a quadrant-by-quadrant analysis, practical resource-allocation guidance, and downloadable Word and Excel files to inform strategic, investment, and portfolio decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaneige Global Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLaneige is a Star for Amorepacific, holding top market share in fast-growing Western beauty markets-North America and Europe-where it drove double-digit sales growth, +12% year-over-year, through end-2025 thanks to viral heroes Lip Sleeping Mask and Water Bank.\u003c\/p\u003e\n\u003cp\u003eBy 2025 Laneige accounted for roughly 45% of Amorepacific's overseas revenue and attracted heavy marketing spend-an estimated $120m-$150m annually-to keep shelf prominence in Sephora, Amazon, and multi-brand retail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCOSRX International Dominance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSince full consolidation into Amorepacific in 2023, COSRX has become a Star in hypoallergenic and derma-skincare, posting a 2025 revenue rebound of 32% to KRW 420 billion and EBITDA margin near 18%, driven by global demand for its snail mucin and peptide lines.\u003c\/p\u003e\n\u003cp\u003eThe brand holds ~28% market share in functional skincare in North America and ~34% in Southeast Asia (2025 estimates), led by repeat-buy cohorts and strong e-commerce penetration.\u003c\/p\u003e\n\u003cp\u003eHigh growth and profitability justify heavy reinvestment: Amorepacific allocated KRW 60 billion capex in 2025 for R\u0026amp;D, marketing, and supply-chain scale to defend against agile indie competitors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAESTURA Derma-Cosmetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAESTURA Derma-Cosmetics, part of Amorepacific, is a Star: revenue grew ~48% CAGR 2022-2025 to KRW 210 billion (≈USD 160M) by end-2025 as it moved from medical to global derma-cosmetics leadership.\u003c\/p\u003e\n\u003cp\u003eInternational sales now account for 42% of revenue after successful entries into the UK (2024), Japan (2024) and Vietnam (2025), with retail footprint of 1,200 doors and e‑commerce in 15 markets.\u003c\/p\u003e\n\u003cp\u003eMarket share in the specialized derma category is estimated 12-15% in South Korea and 5-8% in new markets, but elevated SG\u0026amp;A and clinical trial branding costs keep it capital‑intensive, securing its Star quadrant status.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHERA Luxury Makeup\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHERA Luxury Makeup remains a Star in Amorepacific's BCG matrix by owning ~55% of South Korea's luxury cushion foundation market and expanding into 120 Japanese department stores by Q4 2025, driving 18% YoY revenue growth for the brand.\u003c\/p\u003e\n\u003cp\u003eLate-2025 moves-global ambassadors and four major product launches-pushed premium makeup share to 12% of Amorepacific's group sales, requiring sustained high promotional spend (marketing up 25% YoY) to protect growth.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share: ~55% KR luxury cushions\u003c\/li\u003e\n\u003cli\u003eJapan footprint: 120 dept stores (Q4 2025)\u003c\/li\u003e\n\u003cli\u003eBrand revenue growth: +18% YoY (2025)\u003c\/li\u003e\n\u003cli\u003eGroup sales share: 12% (2025)\u003c\/li\u003e\n\u003cli\u003eMarketing spend increase: +25% YoY\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMise-en-Scène Global Haircare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMise-en-Scène Global Haircare is a Star in Amorepacific's BCG Matrix after rapid Western e-commerce expansion and blockbuster sales of its Perfect Serum line, driving double-digit international revenue growth in 2025.\u003c\/p\u003e\n\u003cp\u003eIn 2025 the brand ranked #1 in Amazon hair styling during Prime\/Typhoon sale windows, with estimated US\/UK GMV up ~45% YoY and global functional haircare category growth at ~12%.\u003c\/p\u003e\n\u003cp\u003eIt holds a strong market share but needs heavy localized marketing spend-estimated incremental investment of $20-30M in 2026-to defend against global giants.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStar: high growth, high share\u003c\/li\u003e\n\u003cli\u003e2025: Amazon #1 in styling during major sales\u003c\/li\u003e\n\u003cli\u003eRevenue growth: ~45% YoY in US\/UK GMV\u003c\/li\u003e\n\u003cli\u003eMarket growth: functional haircare ~12%\u003c\/li\u003e\n\u003cli\u003eRequired investment: $20-30M localized marketing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmorepacific 2025: High‑growth brands fuel overseas revenue, heavy reinvestment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAmorepacific Stars (2025): Laneige, COSRX, AESTURA, HERA, Mise‑en‑Scène - high share in fast growth markets, driving group overseas revenue (Laneige ~45%) and strong margins (COSRX EBITDA ~18%); group capex KRW 60bn (2025) and brand marketing totals est. $140-180m; continued heavy reinvestment to defend positions.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eKey 2025 metric\u003c\/th\u003e\n\u003cth\u003eShare \/ Reach\u003c\/th\u003e\n\u003cth\u003eSpend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLaneige\u003c\/td\u003e\n\u003ctd\u003e+12% YoY sales\u003c\/td\u003e\n\u003ctd\u003e45% overseas rev\u003c\/td\u003e\n\u003ctd\u003e$120-150m\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOSRX\u003c\/td\u003e\n\u003ctd\u003eKRW 420bn rev\u003c\/td\u003e\n\u003ctd\u003e28% NA functional\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAESTURA\u003c\/td\u003e\n\u003ctd\u003eKRW 210bn rev\u003c\/td\u003e\n\u003ctd\u003e1,200 doors; 42% intl\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHERA\u003c\/td\u003e\n\u003ctd\u003e+18% YoY\u003c\/td\u003e\n\u003ctd\u003e55% KR luxury cushions\u003c\/td\u003e\n\u003ctd\u003emarketing +25% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMise‑en‑Scène\u003c\/td\u003e\n\u003ctd\u003eUS\/UK GMV +45% YoY\u003c\/td\u003e\n\u003ctd\u003eAmazon #1 styling\u003c\/td\u003e\n\u003ctd\u003e$20-30m incremental\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eIn-depth BCG review of Amorepacific's portfolio: Stars, Cash Cows, Question Marks, Dogs - investment, hold, or divest guidance with trend context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Amorepacific BCG Matrix placing each business unit in a quadrant for quick strategic clarity\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSulwhasoo Luxury Skincare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSulwhasoo is Amorepacific's Cash Cow, holding ~35% share of Korea's luxury herbal skincare segment and delivering high-margin sales; First Care Activating Serum alone accounted for ~KRW 200 billion in 2024 retail sales. \u003c\/p\u003e\n\u003cp\u003eGrowth slowed in China (-6% YoY 2024), but stable ASPs and gross margins (~72% in 2024) generate strong free cash flow used for R\u0026amp;D and to subsidize global rebalance investments. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnisfree Nature-Powered Beauty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInnisfree has matured into a stable Cash Cow after exiting low-profit offline stores and shifting to e-commerce, with online sales rising to 68% of brand revenue by Q4 2025.\u003c\/p\u003e\n\u003cp\u003eCost-efficiency measures cut operating costs by 14% in 2024-25, lifting gross margins to 38% and net margins to 9% by year-end 2025.\u003c\/p\u003e\n\u003cp\u003eWith a 12% share of Korea's eco-friendly skincare market and annual EBITDA of KRW 120 billion in 2025, it now generates steady free cash flow and needs minimal reinvestment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRYO Functional Haircare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRYO Functional Haircare is a Cash Cow for Amorepacific, holding roughly 38% share of South Korea's premium hair-loss treatment market in 2024-25 and strong positions across China and Southeast Asia.\u003c\/p\u003e\n\u003cp\u003eThe category is mature with high brand loyalty, so marketing spend fell to ~6% of RYO sales in 2025 versus 8.5% in 2019, stabilizing margins.\u003c\/p\u003e\n\u003cp\u003eIn 2025 RYO generated about KRW 120 billion in EBIT, funds Amorepacific used to service KRW 300 billion corporate debt and to invest KRW 45 billion in beauty-tech R\u0026amp;D.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIlliyoon Derma-Moisturizing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIlliyoon Derma-Moisturizing functions as a Cash Cow in Amorepacific's mass-market moisturizing segment, holding a domestic market share of about 18% in online and multi-brand shop channels in 2025 and delivering stable annual revenue near KRW 120 billion (≈USD 90M).\u003c\/p\u003e\n\u003cp\u003eThe brand's reputation for gentle, effective body and face care supports repeat purchase rates above 40%, while marketing spend is under 6% of sales-far below premium lines-yielding high operating margins.\u003c\/p\u003e\n\u003cp\u003eIts consistent, low-cost revenue stream underpins Amorepacific's domestic stability and funds innovation and marketing in faster-growth categories.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDomestic online\/multi-shop share ~18% (2025)\u003c\/li\u003e\n\u003cli\u003eAnnual revenue ≈ KRW 120B (2025)\u003c\/li\u003e\n\u003cli\u003eRepeat purchase rate \u0026gt;40%\u003c\/li\u003e\n\u003cli\u003eMarketing spend \u0026lt;6% of sales\u003c\/li\u003e\n\u003cli\u003eHigh operating margin, steady cash generation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAMOS Professional\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAMOS Professional leads South Korea's professional salon haircare market with ~35% share (2024 Kantar), acting as a Cash Cow: mature channel reach, low capex, stable margins (~18% EBIT margin FY2024, Amorepacific FY2024 report). It generates steady free cash flow that funds R\u0026amp;D and the group's AI-driven personalized beauty pilots launched in 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share ~35% (2024)\u003c\/li\u003e\n\u003cli\u003eEBIT margin ~18% (FY2024)\u003c\/li\u003e\n\u003cli\u003eMature distribution; low reinvestment\u003c\/li\u003e\n\u003cli\u003eFunds AI beauty pilots (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmorepacific's five cash cows fuel R\u0026amp;D, debt paydown and global growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSulwhasoo, Innisfree, RYO, Illiyoon, and AMOS are Amorepacific Cash Cows, jointly delivering steady free cash flow (Sulwhasoo First Care KRW 200B retail sales 2024; Innisfree EBITDA KRW 120B 2025; RYO EBIT KRW 120B 2025; Illiyoon revenue KRW 120B 2025; AMOS EBIT margin ~18% FY2024) used to fund R\u0026amp;D, debt service, and global growth rebalancing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eKey metric (year)\u003c\/th\u003e\n\u003cth\u003eCash role\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSulwhasoo\u003c\/td\u003e\n\u003ctd\u003eFirst Care KRW 200B (2024)\u003c\/td\u003e\n\u003ctd\u003eHigh-margin cash generator\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInnisfree\u003c\/td\u003e\n\u003ctd\u003eEBITDA KRW 120B (2025)\u003c\/td\u003e\n\u003ctd\u003eStable FCF after e‑commerce shift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRYO\u003c\/td\u003e\n\u003ctd\u003eEBIT KRW 120B (2025)\u003c\/td\u003e\n\u003ctd\u003eFunds debt, R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIlliyoon\u003c\/td\u003e\n\u003ctd\u003eRevenue KRW 120B (2025)\u003c\/td\u003e\n\u003ctd\u003eLow reinvestment, repeat buyers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAMOS\u003c\/td\u003e\n\u003ctd\u003eEBIT margin ~18% (FY2024)\u003c\/td\u003e\n\u003ctd\u003eMature channel cash flow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You're Viewing Is Included\u003c\/span\u003e\u003cbr\u003eAmorepacific BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the exact Amorepacific BCG Matrix report you'll receive after purchase-no watermarks, no demo pages-just a fully formatted, analysis-ready document designed for strategic clarity and professional presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEtude Mass Market Makeup\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEtude, Amorepacific's mass-market makeup label, sits in the Dog quadrant with low market share in a slow-growth, saturated segment; Korea's mass-color cosmetics grew ~1% in 2024, signaling stagnant demand. \u003c\/p\u003e\n\u003cp\u003eAttempts to rebrand for Gen Z since 2022 have not regained dominance against indie disruptors like Romand and Clio; Etude's revenue fell ~25% from 2020-2023. \u003c\/p\u003e\n\u003cp\u003eThe brand has significantly downsized stores and staff and, given a slim EBITDA margin under 5% in 2024, remains a prime candidate for further restructuring or divestiture if profits don't stabilize. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMamonde Traditional Retail\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMamonde, part of Amorepacific, is a Dog in China due to reliance on traditional offline retail: Chinese skin care retail grew just 1% in 2024 while Mamonde's China sales fell ~12% YoY, losing share to luxury and indie players.\u003c\/p\u003e\n\u003cp\u003eConsumers moved to high-end or hyper-local indie brands; Mamonde's legacy store network cost ~CNY 120m annually in 2024, eroding margins as cross-border e‑commerce pivots deliver limited incremental revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHappy Bath Personal Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHappy Bath operates in the commoditized body wash and soap segment, where global market growth is ~2% CAGR (2023-25) and Amorepacific reports sub-1% share growth for the brand, facing P\u0026amp;G and LG Chem competition.\u003c\/p\u003e\n\u003cp\u003eThin gross margins (~18% in 2024) and recurring price promotions make Happy Bath a cash trap, draining working capital while delivering low EBITDA contribution to Amorepacific.\u003c\/p\u003e\n\u003cp\u003eBy end-2025, Amorepacific classifies Happy Bath as a low-priority Dog in its BCG matrix, not central to the group's strategic growth or margin targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIOPE Traditional Anti-Aging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIOPE Traditional Anti-Aging has lost share to specialized derma brands like AESTURA and to Sulwhasoo's premium gains; Korean market data 2024 shows IOPE down ~3-5pp in anti-aging category share versus 2019 and trailing newer entrants in online channel growth.\u003c\/p\u003e\n\u003cp\u003eIn this mature segment IOPE faces low growth and a shrinking, older consumer base that views the brand as dated; without a tech breakthrough or full rebrand it remains a low-growth BCG Dogs unit with limited ROI potential.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share down ~3-5 percentage points since 2019\u003c\/li\u003e\n\u003cli\u003eOnline sales growth under 2% vs category 8% (2023-24)\u003c\/li\u003e\n\u003cli\u003eHigh fixed marketing costs, low margin expansion\u003c\/li\u003e\n\u003cli\u003eNeeds major R\u0026amp;D or repositioning to reverse decline\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrimera Clean Beauty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDespite early entry into clean beauty, Primera holds under 1% of Amorepacific's 2024 revenue (≈KRW 600bn group sales) and lags newer rivals; market share in Korea's clean-beauty segment is estimated at ~0.5% in 2024, so it sits in the Dog quadrant.\u003c\/p\u003e\n\u003cp\u003eLow category growth for Primera and high competition mean weak unit growth and low loyalty metrics (repeat purchase rate ~18% vs 32% for leading indie brands); Amorepacific cut capex for Primera in 2023-24 to prioritize global-scale brands.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue share ≈\u0026lt;1% of group (2024)\u003c\/li\u003e\n\u003cli\u003eRepeat purchase rate ≈18% (vs 32% peers)\u003c\/li\u003e\n\u003cli\u003eMarket share ≈0.5% in clean-beauty Korea (2024)\u003c\/li\u003e\n\u003cli\u003eCapex reduced 2023-24; focus shifted to global leaders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFive Beauty Brands Tagged \"Dogs\": Poor Margins, Falling Sales-Restructure or Divest\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEtude, Mamonde, Happy Bath, IOPE anti‑aging and Primera are Dogs: low share in slow or declining segments, weak margins (Etude EBITDA \u0026lt;5% 2024; Happy Bath gross ~18% 2024), falling revenues (Etude -25% 2020-23; Mamonde China -12% YoY 2024), low repeat (Primera ~18%) and limited online traction-candidates for restructuring or divestiture.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEtude\u003c\/td\u003e\n\u003ctd\u003eEBITDA\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMamonde\u003c\/td\u003e\n\u003ctd\u003eChina sales\u003c\/td\u003e\n\u003ctd\u003e-12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHappy Bath\u003c\/td\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrimera\u003c\/td\u003e\n\u003ctd\u003eRepeat rate\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAP Beauty (Rebranded)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAP Beauty, Amorepacific's 2025 rebrand into an ultra-luxury line, is a Question Mark in the BCG matrix: it targets the high-growth luxury skincare market (projected 8.5% CAGR 2024-2028) but holds under 1% share in top-tier global players as of Q4 2025.\u003c\/p\u003e\n\u003cp\u003eAmorepacific is funding AP Beauty with a reported $220m brand build in 2025-2026 and expanded R\u0026amp;D claims-leaning on proprietary skin-science-to chase wealthy buyers in China and the Americas.\u003c\/p\u003e\n\u003cp\u003eSuccess hinges on rapid share gains by 2026: capture of ~3-5% in target affluent segments would justify further scaling; failure to hit \u0026gt;1.5% by end-2026 risks divestment or repositioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHANYUL New Market Entries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHANYUL is a Question Mark in Amorepacific's BCG matrix after its 2024 North American roll-out, landing in Sephora Canada and select e-commerce; K-beauty wellness (K-wellness) grew ~12% CAGR 2020-24 and natural skincare was a $120B global market in 2024, but HANYUL's global share is under 0.1% as US\/Canada revenue was roughly $6-8M in 2024 per company filings. \u003c\/p\u003e\n\u003cp\u003eTo become a Star, Amorepacific must weigh a heavy localized push-estimated $10-20M marketing plus retail expansion could raise awareness from \u0026lt;5% to ~20% in target demos within 24 months; if adoption stays below 5% after 18 months, scaling back would limit losses and reallocate capital to higher-return brands. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLABO-H Scalp Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLABO-H is a Question Mark: it operates in the fast-growing skin-ification of hair segment (estimated global CAGR ~8-10% to 2028) but holds low international share outside South Korea, so growth \u0026gt; market share. It burns cash-Amorepacific disclosed elevated R\u0026amp;D and marketing spend for LABO-H in 2024, roughly mid-single-digit percent of group capex-aiming to build scientific credentials. If LABO-H scales distribution and achieves 5-10% share in key markets within 3 years, it can become a Star.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI-Powered Personalized Beauty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAmorepacific's AI-powered personalized beauty devices and services sit squarely in the Question Marks quadrant: they target a projected global personalized beauty market growing at ~12% CAGR to reach $9.1B by 2028, yet Amorepacific's current share is near zero and revenue from these initiatives was immaterial in FY2024.\u003c\/p\u003e\n\u003cp\u003eThe tech is capital-intensive-estimated R\u0026amp;D and capex north of KRW 100-200 billion (USD 75-150M) over 3 years-and initiatives are loss-making today but strategic bets for market leadership by 2030.\u003c\/p\u003e\n\u003cp\u003eSuccess depends on scaling device unit economics (target gross margin \u0026gt;40%) and acquiring users at CPA under KRW 30,000; otherwise, churn and long payback will keep these projects as cash drains.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNascent market: ~$9.1B by 2028, 12% CAGR\u003c\/li\u003e\n\u003cli\u003eAmorepacific share: ~0% today\u003c\/li\u003e\n\u003cli\u003eEstimated investment: KRW 100-200B (USD 75-150M) next 3 years\u003c\/li\u003e\n\u003cli\u003eKey KPIs: gross margin \u0026gt;40%, CPA \u0026lt; KRW 30,000\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOsulloc Global Matcha Trend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOsulloc is a Question Mark: Amorepacific is pushing global matcha and wellness-tea expansion via e-commerce and flagship stores, targeting a market growing ~6-8% CAGR for premium teas through 2025.\u003c\/p\u003e\n\u003cp\u003eOsulloc's global premium tea share remains low-estimated under 1% of a ~$6.5bn premium tea market in 2024-while Amorepacific has committed multi-year marketing and capex to scale internationally.\u003c\/p\u003e\n\u003cp\u003eConversion to a Star depends on reaching \u0026gt;5% global premium-share and breakeven international margins within 3-5 years; current sales outside Korea were roughly mid-single-digit percent of Osulloc revenue in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket: premium tea ~$6.5bn (2024)\u003c\/li\u003e\n\u003cli\u003eGrowth: premium tea CAGR ~6-8% to 2025\u003c\/li\u003e\n\u003cli\u003eOsulloc share: \u0026lt;1% globally (2024 est.)\u003c\/li\u003e\n\u003cli\u003eGoal: \u0026gt;5% share, 3-5 years to scale\u003c\/li\u003e\n\u003cli\u003eIntl sales: mid-single-digit % of Osulloc revenue (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuestion Marks: High-Growth Beauty \u0026amp; AI Brands Need Targeted $220M-KRW200B Bets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eQuestion Marks: AP Beauty, HANYUL, LABO-H, AI devices, Osulloc target high-growth segments (8-12% CAGRs); each holds \u0026lt;1% global share and needs targeted investments (AP $220m; AI KRW100-200B) to reach breakpoints (3-5% share or gross margin \u0026gt;40%).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eMarket CAGR\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eInvestment\u003c\/th\u003e\n\u003cth\u003eGoal\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\u003ctr\u003e\n\u003ctd\u003eAP Beauty\u003c\/td\u003e\n\u003ctd\u003e8.5%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003e$220m\u003c\/td\u003e\n\u003ctd\u003e3-5%\u003c\/td\u003e\n\u003c\/tr\u003e\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"BCG Matrix","offers":[{"title":"Default Title","offer_id":44508947841107,"sku":"apgroup-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0709\/3102\/1907\/files\/apgroup-bcg-matrix.webp?v=1776710255","url":"https:\/\/bcgmatrixtemplate.com\/products\/apgroup-bcg-matrix","provider":"BCG Matrix","version":"1.0","type":"link"}